Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional studyArticle Published on 2022-12-012022-11-15 Journal: Rheumatology International [Category] 바이오마커, 진단, [키워드] Active disease ANCA-associated vasculitis Care clinical manifestations Cohort conducted COVID-19 COVID-19 infection COVID-19 severity Critical cross-sectional Cyclophosphamide death demographic died Disease activity Features Follow-up General population Immunosuppressant increased risk India Infection managing moderate non-COVID-19 patient not differ ocular outcome Patient patients patients died predicted receiving regimen required risk of COVID-19 rituximab SARS-CoV-2. severity single-center Supplemental oxygen therapy the patient Treatment Univariate analysis Vasculitis [DOI] 10.1007/s00296-022-05177-2 PMC 바로가기
Post COVID-19 condition of the Omicron variant of SARS-CoV-2Research article Published on 2022-11-012022-10-05 Journal: Journal of infection and chemotherapy : official j [Category] SARS, 변종, [키워드] both group Characteristics condition conducted control group controls coronavirus disease covariate COVID-19 COVID-19 infection COVID-19-related symptom cross-sectional defined Epidemiology female in both group information investigated less Long COVID no significant difference obesity objective Older omicron Patient Post COVID-19 conditions Prevalence propensity score matching Quality of life questionnaire Research response Result Sample size Sex single-center strain Strains Symptom two groups vaccination variant variant of SARS-CoV-2 WHO definition [DOI] 10.1016/j.jiac.2022.08.007 [Article Type] Research article
A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in BelgiumResearch article Published on 2022-11-012022-10-05 Journal: Journal of infection and chemotherapy : official j [Category] 진단, 치료기술, [키워드] Admission Analysis bacterial superinfection Belgium cardiovascular complication cohort study COVID-19 COVID-19 pandemic COVID-19 patient died difference ECMO Health hospital hospitalized patient ICU ICU admission in-hospital mortality increased risk Influenza influenza infection intensive care Intubation rates morbidity and mortality Mortality outcome Outcome comparison Patient patients with COVID-19 patients with influenza Propensity score matched analysis readmission required Result retrospective Seasonal influenza secondary severity single-center with COVID-19 [DOI] 10.1016/j.jiac.2022.07.012 [Article Type] Research article
Urticaria relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single-center experienceArticle Published on 2022-11-012022-11-15 Journal: Dermatologic therapy [Category] 진단, [키워드] acute urticaria adverse event affected analyzed appear characterized chronic chronic spontaneous urticaria Clinical characteristics Coronavirus disease 2019 COVID-19 COVID-19 vaccine described develop disease Frequency IgE less mechanism mRNA mRNA COVID-19 vaccine mRNA vaccines occur pandemic Patient patients treated Retrospective study single-center treated urticaria vaccination Vaccine wheals. [DOI] 10.1111/dth.15838 PMC 바로가기
Low Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission by Fomites: A Clinical Observational Study in Highly Infectious Coronavirus Disease 2019 PatientsArticle Published on 2022-11-012022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 치료기술, [키워드] acute respiratory syndrome addressed baseline carrier Cell culture clinical coronavirus 2 coronavirus disease Coronavirus-2 coughing COVID-19 COVID-19 patient Culture Cycle threshold value evaluate fomite transmission Hospitalized Infectious virus initiated Intensive laboratory parameter occur oropharyngeal swab pandemic Patient polymerase chain positive Quantitative respiratory risk Saliva SARS-CoV-2 SARS-CoV-2 transmission Sequencing single-center stability surface stability. Swab Transmission unlikely Viral load viral ribonucleic acid virus virus transmission [DOI] 10.1093/infdis/jiac170 PMC 바로가기
Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort StudyArticle Published on 2022-10-252022-11-16 Journal: Journal of the Pediatric Infectious Diseases Socie [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI age Alpha analyses children clinical Community concern coronavirus 2 COVID-19 COVID-19 infection COVID-19 severity diagnosed with COVID-19 FIVE Frequency Gamma Hospitalization ICU admission illness Illumina immunization incidence increasing age marker medical condition Medical conditions outcome outcomes performed pharmacologic treatment prevented recent Regression model respiratory Respiratory Support retrospective cohort study SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 variant scale Sequencing severe COVID-19 severe disease severity Severity. single-center the WHO VoC VOCs were infected with COVID-19 [DOI] 10.1093/jpids/piac068 PMC 바로가기
Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational studyArticle Published on 2022-10-242022-11-16 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome Admission analysis Analysis clearance clinical Comorbidity Coronary heart disease coronavirus Ct values cycle threshold determinant diabetes equation evaluate Frame Generalized group hospitalized patient hypertension Infection male material median age multivariable analysis N gene nasopharyngeal nucleocapsid protein omicron ORF ORF 1ab gene Patient patients with SARS-CoV-2 positive predictor predictors prolonged SARS-CoV-2 RNA shedding. prolonged viral shedding proportion receiving remained retrospective Retrospective study RT-PCR SARS-CoV-2 SARS-CoV-2 Omicron variant SARS-CoV-2 RNA significantly single-center tested the timing vaccination Vaccinations Vaccine variant viral clearance viral RNA clearance Viral RNA shedding [DOI] 10.3389/fpubh.2022.1015811 PMC 바로가기
Reliability and clinical correlations of semi-quantitative lung ultrasound on BLUE points in COVID-19 mechanically ventilated patients: The ‘BLUE-LUSS’-A feasibility clinical studyArticle Published on 2022-10-142022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술, [키워드] clinical study correlated correlation COVID-19 COVID-19 pandemic Critically ill Critically ill patient critically ill patients diagnostic feasibility ICUs independent indicated information intensive care intensive care unit Intervention lung Lung pathology mechanically ventilated P/F P/F ratio positive reduce Region reliability risk of infection RT-PCR SARS-CoV2 semi-quantitative significantly single-center the patient Treatment university Variability ventilated patient was performed were recorded [DOI] 10.1371/journal.pone.0276213 PMC 바로가기
Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in JapanArticle Published on 2022-10-052022-11-16 Journal: Medicina [Category] COVID19(2023년), SARS, 변종, [키워드] 113 patient and post COVID-19 condition caused change changes in Characteristics characterized cough COVID COVID patient COVID-19 delta variant dysgeusia dysosmia fatigue Frequency hospitalizations illnesses Insomnia Japan Long manifestation material myalgic encephalomyelitis/chronic fatigue syndrome. objective omicron Omicron variant outpatient clinic Patient patients prevalent Result retrospective significantly significantly lower single-center Symptom syndrome the patient three groups university vaccination variant variants viral variant were infected [DOI] 10.3390/medicina58101393 PMC 바로가기
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsArticle Published on 2022-10-012022-11-15 Journal: Transfusion [Category] COVID19(2023년), SARS, 진단, [키워드] 28-day mortality acute respiratory syndrome administration adverse effects adverse event adverse events antibody antibody assay Antibody Response Antibody titers Antigen assays binding case-control study CCP Characteristics characterization Control Controlled trial convalescent convalescent plasma coronavirus COVID-19 COVID-19 convalescent plasma died disease severity Donor donors enrolled evaluated group had no heterogeneous hospital Hospitalized immune response Immunosuppressed median median age Microarray NAb Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing antibody assays neutralizing capacity not affect pathogen-reduction treatment. Patient Pneumonia recipient recipients response responses SARS CoV-2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV2 single-center survival symptom onset transfused transfusion treated Treatment variable with COVID-19 [DOI] 10.1111/trf.17083 PMC 바로가기